EP3429571
Samsetningar af LSD1 hindrum til notkunar við meðhöndlun á æxlissjúdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.3.2017EP published:
8.10.2025EP application number:
17710261.3
EP translation filed:
2.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
12.3.2037Expiry date:
12.3.2027Next due date:
31.3.2027
Title in English:
COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASESLanguage of the patent:
English
Timeline
Today
13.3.2017EP application
8.10.2025EP Publication
2.1.2026Translation submitted
11.2.2026Registration published
12.3.2027Expires
Owner
Name:
Oryzon Genomics, S.A.Address:
Carrera de San Jérónimo 15 2nd floor, 28014 Madrid, ES
Inventor
Name:
DEMARIO, MarkAddress:
New York NY 10016, US
Name:
PIERCEALL, WilliamAddress:
New York NY 10016, US
Name:
MACK, FionaAddress:
New York NY 10016, US
Name:
MAES, TamaraAddress:
08940 Cornellà de Llobregat, ES
Name:
LUNARDI, SerenaAddress:
08940 Cornellà de Llobregat, ES
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662308529 PDate:
15.3.2016Country:
US
Classification
Categories:
A61K 31/4745, A61K 31/12, A61P 35/00, A61K 31/7068, A61K 31/704, A61K 31/555, A61K 31/519, A61K 31/495, A61K 31/475, A61K 31/4045, A61K 31/337, A61K 31/282, A61K 31/19, A61K 31/135, A61K 31/167, A61K 31/404, A61K 31/4545, A61K 31/52, A61K 31/496, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 28.3.2026
Expires: 12.3.2027
Payer: Árnason Faktor ehf.